Evaluation of POLE and POLD1 mutations as biomarkers for immunotherapy outcomes across multiple cancer types

F Wang, Q Zhao, YN Wang, Y Jin, MM He, ZX Liu… - JAMA …, 2019 - jamanetwork.com
Discussion| Our findings extend prior research in other settings1-3 to support visible,
innovative actions by oncology meeting organizers, including women's networking centers
and facilitation of childcare services, as steps to ensure full participation of all those who
might contribute or benefit at conferences. 4 The primary limitations of this study are that the
data were self-reported and respondents (55% response rate) might not be representative of
the full population. We did not measure training institution or socioeconomic status (which …